Company Overview
About Orca Bio
Orca Bio is a Menlo Park, California-based biotechnology company founded in 2016 that is developing next-generation cell therapies for blood cancers and autoimmune diseases through a proprietary high-precision cell sorting and manufacturing platform. The company's core technology enables the production of precisely defined cell therapy products — specifically, highly purified stem cell grafts and engineered immune cell compositions for allogeneic (donor-to-patient) bone marrow transplantation. Unlike conventional bone marrow transplants, which transfer a heterogeneous mixture of cells that can attack the patient's body (graft-versus-host disease, or GVHD), Orca Bio's manufactured grafts are composed of precisely selected cell populations that retain the anti-cancer effect while dramatically reducing the cells responsible for GVHD.
Business Model & Competitive Advantage
Orca Bio has raised over $270M from investors including New Enterprise Associates (NEA), Blackstone Life Sciences, Monashee Investment Management, and Foresite Capital. The company's lead clinical programs target acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients undergoing allogeneic bone marrow transplantation. Phase 2 clinical data has demonstrated GVHD rates dramatically lower than historical benchmarks for conventional transplantation — a result that, if confirmed in registrational trials, would represent a major advance in the treatment of these life-threatening blood cancers. The company is advancing toward a Phase 3 pivotal trial and a potential BLA submission to the FDA.
Competitive Landscape 2025–2026
Orca Bio sits at the intersection of three of the most active areas in oncology: cell therapy (pioneered by CAR-T leaders like Bristol-Myers Squibb and Kite/Gilead), precision medicine (enabled by advances in single-cell biology), and transplant immunology. The company competes in the allogeneic cell therapy space alongside companies like Magenta Therapeutics (acquired), Vor Biopharma, and Editas Medicine in adjacent gene editing approaches, but Orca Bio's precision cell manufacturing platform represents a distinct technical approach that is further along clinically than most competitors working on next-generation transplant platforms. If approved, Orca Bio's product could become a standard of care for the tens of thousands of patients who receive allogeneic bone marrow transplants annually in the US.
Key Differentiators
Emerging Innovator
Orca Bio is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Compare Orca Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Orca Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Orca Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Orca Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →